Genmab A/S
GNMSF
$241.84
-$3.16-1.29%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 65.52% | 1.56% | 441.45% | -39.29% | 4.07% |
| Total Depreciation and Amortization | 14.29% | 23.08% | 96.28% | 32.95% | -26.86% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -281.37% | 102.13% | -254.78% | 2,631.13% | 59.75% |
| Change in Net Operating Assets | -5.00% | 22.95% | -28.00% | -403.55% | 53.35% |
| Cash from Operations | -71.69% | 31.05% | 60.57% | 0.70% | 243.77% |
| Capital Expenditure | -150.00% | -200.00% | -38.89% | 60.87% | 71.78% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -93.04% | 84.95% | 146.46% | -76.10% | 303.59% |
| Cash from Investing | 102.05% | 79.52% | 118.37% | -77.58% | -373.68% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -33.33% | 33.33% | 100.00% | -6.25% | 89.66% |
| Issuance of Common Stock | 200.00% | -88.89% | 22.22% | 7.50% | -97.18% |
| Repurchase of Common Stock | 7.06% | 86.81% | -33.33% | -7,450.00% | -1,154.29% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 7.73% | 84.71% | 113.50% | -1,492.45% | -43,119.16% |
| Foreign Exchange rate Adjustments | 64.29% | 900.00% | 215.93% | -90.94% | -335.54% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 78.54% | 410.39% | 485.98% | -40.30% | -628.46% |